Driscoll David F, Thoma Andrea, Franke Rolf, Klütsch Karsten, Nehne Jörg, Bistrian Bruce R
Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA.
Am J Health Syst Pharm. 2009 Apr 1;66(7):649-56. doi: 10.2146/ajhp080164.
The stability of injectable lipid emulsions in three-chamber plastic (3CP) bags, applying the globule-size limits established by United States Pharmacopeia ( USP ) chapter 729, was studied.
A total of five premixed total nutrient admixture (TNA) products packaged in 3CP bags from two different lipid manufacturers containing either 20% soybean oil or a mixture of soybean oil and medium-chain-triglyceride oil as injectable lipid emulsions were tested. Two low-osmolarity 3CP bags and three high-osmolarity 3CP bags were studied. All products were tested with the addition of trace elements and multivitamins. All additive conditions (with and without electrolytes) were tested in triplicate at time 0 (immediately after mixing) and at 6, 24, 30, and 48 hours after mixing; the bags were stored at 24-26 degrees C. All additives were equally distributed in each bag for comparative testing, applying both globule sizing methods outlined in USP chapter 729.
Of the bags tested, all bags from one manufacturer were coarse emulsions, showing signs of significant growth in the large-diameter tail when mixed as a TNA formulation and failing the limits set by method II of USP chapter 729 from the outset and throughout the study, while the bags from the other manufacturer were fine emulsions and met these limits. Of the bags that failed, significant instability was noted in one series containing additional electrolytes.
Injectable lipid emulsions provided in 3CP bags that did not meet the globule-size limits of USP chapter 729 produced coarser TNA formulations than emulsions that met the USP limits.
研究了按照美国药典(USP)第729章规定的液滴尺寸限制,注射用脂质乳剂在三室塑料(3CP)袋中的稳定性。
测试了总共五种预混全营养混合液(TNA)产品,这些产品包装在来自两家不同脂质制造商的3CP袋中,含有20%的大豆油或大豆油与中链甘油三酯油的混合物作为注射用脂质乳剂。研究了两个低渗透压3CP袋和三个高渗透压3CP袋。所有产品都添加微量元素和多种维生素进行测试。所有添加条件(有电解质和无电解质)在混合后0小时(立即混合后)以及混合后6、24、30和48小时进行一式三份测试;袋子在24 - 26摄氏度下储存。所有添加剂在每个袋子中均匀分布以进行对比测试,采用USP第729章概述的两种液滴尺寸测量方法。
在测试的袋子中,来自一个制造商的所有袋子都是粗乳液型,当作为TNA制剂混合时,在大直径尾部显示出显著增长的迹象,从一开始到整个研究过程都未达到USP第729章方法II设定的限值,而来自另一个制造商的袋子是细乳液型且符合这些限值。在未达标的袋子中,在一个含有额外电解质的系列中观察到显著的不稳定性。
3CP袋中提供的不符合USP第729章液滴尺寸限制的注射用脂质乳剂,与符合USP限值的乳剂相比,会产生更粗的TNA制剂。